<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010007718">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACLN : Articles dans des revues avec comité de lecture non répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Leroy, V.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Msellati, Philippe</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Lepage, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Batungwanayo, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hitimana, D.G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Taelman, H.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Bogaerts, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Boineau, F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Van de Perre, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Simonon, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Salamon, R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Dabis, F.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Four years of natural history of HIV-1 infection in African women : a prospective cohort study in Kigali (Rwanda), 1988-1993</title>
        <secondary-title>Journal of Acquired of Immune Deficiency Syndromes and Human Retrovirology</secondary-title>
      </titles>
      <pages>415-421</pages>
      <keywords>
        <keyword>SIDA</keyword>
        <keyword>EPIDEMIOLOGIE</keyword>
        <keyword>MORTALITE</keyword>
        <keyword>FEMME</keyword>
        <keyword>GROSSESSE</keyword>
        <keyword>MALADIES ASSOCIEES</keyword>
        <keyword>DIAGNOSTIC</keyword>
        <keyword>TUBERCULOSE</keyword>
        <keyword>VIRUS HIV-1</keyword>
        <keyword>RWANDA</keyword>
        <keyword>KIGALI</keyword>
      </keywords>
      <dates>
        <year>1995</year>
      </dates>
      <call-num>fdi:010007718</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Journal of Acquired of Immune Deficiency Syndromes and Human Retrovirology</full-title>
      </periodical>
      <isbn>0894-9255</isbn>
      <number>4</number>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010007718</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/pleins_textes_6/b_fdi_45-46/010007718.pdf</url>
        </pdf-urls>
      </urls>
      <volume>9</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Clinical features and mortality due to human immunodeficiency virus type-1 (HIV-1) infection in women are described as part of a prospective 4-year cohort study on perinatal transmission of HIV in Kigali, Rwanda. Two hundred fifteen HIV-positive (HIV+) and 216 HIV-negative (HIV-) pregnant women were enrolled at delivery between November 1988 and June 1989. Clinical information collected during systematic quarterly examinations was compared. HIV antibody tests were performed at delivery and CD4/CD8 lymphocyte counts at 15 days' postpartum. HIV- women who seroconverted during the follow-up period were excluded from the analysis of the comparison group starting at the date of seroconversion. At enrollment, all HIV+ women were asymptomatic for acquired immune deficiency syndrome (AIDS). Incidence of tuberculosis was 2.9 per 100 women-years (WY) after 4 years of follow-up in HIV+ women versus 0.2 per 100 WY among HIV- women (relative risk. 18.2% ; 95% confidence interval 2.4-137.0). Among HIV+ women, the incidence of AIDS was 3.5 per 100 WY. The mortality rate was 4.4 per 100 WY among HIV+ women versus 0.5 per 100 WY among HIV- women. Clinical AIDS was present in only half of the fatalities. Tuberculosis was a major cause of morbidity and mortality in these HIV+ African women. An early diagnosis and an appropriate treatment or prevention of tuberculosis should improve the quality of life of HIV-infected patients in Africa. (Résumé d'auteur)</abstract>
      <custom6>052MALTRA03</custom6>
    </record>
  </records>
</xml>
